Breaking News Instant updates and real-time market news.

VRTX

Vertex

$151.60

-3.21 (-2.07%)

04:55
06/27/18
06/27
04:55
06/27/18
04:55

Vertex management to meet with UBS

Meetings to be held June 25-June 27 hosted by UBS.

  • 27

    Jun

  • 12

    Jul

VRTX Vertex
$151.60

-3.21 (-2.07%)

06/07/18
HCWC
06/07/18
NO CHANGE
Target $15
HCWC
Buy
Proteostasis data bring more questions than answers, says H.C. Wainwrigh
H.C. Wainwright analyst Andrew Fein sees more questions than answers after Proteostasis Therapeutics (PTI) reported the initial outcome of its 801-01 clinical trial comprising 14 day dosing of PTI-801, a second generator corrector on top of Vertex's (VRTX) Orkambi. In the analyst's opinion, the trial met its primary objective of demonstrating safety and tolerability for three different doses of PTI-801. However, Proteostasis reported on a series of outcome measurements that "generated some positive data, some negative data and some somewhat confusing data," the analyst adds. In the end, he feels the data set is "somewhat incompletely baked and provides more questions than answers." Fein has a Buy rating on Proteostasis with a $15 price target.
06/07/18
RBCM
06/07/18
NO CHANGE
Target $202
RBCM
Outperform
Vertex weakness into readout of Galapagos data 'unfounded,' says RBC Capital
Following the read-through from Proteostasis' (PTI) data for PTI-801 in CF patients on background Orkambi therapy, RBC Capital analyst Brian Abrahams reaffirmed his view that weakness in Vertex (VRTX) into the readout of similar Phase II CF study data from Galapagos (GLPG) is "unfounded" and presents a buying opportunity for Vertex shares. Abrahams has an Outperform rating and $202 price target on Vertex shares.
06/12/18
ARGS
06/12/18
NO CHANGE
Target $172
ARGS
Buy
Vertex price target lowered to $172 from $194 at Argus
Argus analyst Jasper Hellweg lowered his price target on Vertex to $172 to reflect the 15% decline in the stock price over the past quarter driven by the overall weakness in the biopharma sector. Longer term, the analyst keeps his Buy rating and believes the current levels offer a buying opportunity, saying he is positive on the company's product lineup and deep pipeline focusing on cystic fibrosis. Hellweg adds that the valuation on Vertex is also favorable, with the stock trading at 46.4-times his FY18 EPS estimate vs. the 3-year historical average of 71.2-times.
06/15/18
OPCO
06/15/18
NO CHANGE
OPCO
Outperform
Large-cap biotech fundamentals slowly improving, says Oppenheimer
Ahead of Q2 biotech earnings starting in mid-July, Oppenheimer analyst Hartaj Singh tells investors in a research note that large-cap fundamentals and sector sentiment are "slowly but surely" improving. Improving fundamentals indicate that large-cap biotech results could outperform in Q2, with Gilead (GILD), Alexion (ALXN) and Vertex (VRTX) leading the charge. Singh called out Vertex as "one of our favorite large-cap biotech names," and also says he believes the negative sentiment around Regeneron (REGN) "might be peaking." Singh, who has Outperform ratings on Alexion and Vertex and a Perform rating on Gilead and Regeneron, says he is "cautiously bullish" on the sector.

TODAY'S FREE FLY STORIES

NOC

Northrop Grumman

$288.84

2.54 (0.89%)

17:13
02/22/19
02/22
17:13
02/22/19
17:13
Hot Stocks
Northrop Grumman exec Kalan sells 4,312 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYB

LyondellBasell

$89.14

0.63 (0.71%)

17:07
02/22/19
02/22
17:07
02/22/19
17:07
Syndicate
Breaking Syndicate news story on LyondellBasell »

LyondellBasell files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCCO

Technical Comm Corp

$2.76

0.17 (6.56%)

17:06
02/22/19
02/22
17:06
02/22/19
17:06
Hot Stocks
Technical Comm Corp to submit plan to regain compliance with Nasdaq by March 4 »

Technical Comm Corp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INFU

InfuSystem

$4.15

0.04 (0.97%)

17:01
02/22/19
02/22
17:01
02/22/19
17:01
Hot Stocks
InfuSystem announces settlement of derivative lawsuit »

InfuSystem Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KALU

Kaiser Aluminum

$108.22

-1.9 (-1.73%)

17:01
02/22/19
02/22
17:01
02/22/19
17:01
Hot Stocks
Kaiser Aluminum names Neal West as new CFO »

Kaiser Aluminum announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALDR

Alder Biopharmaceuticals

$14.35

0.19 (1.34%)

17:00
02/22/19
02/22
17:00
02/22/19
17:00
Hot Stocks
Alder Biopharmaceuticals submits eptinezumab BLA to FDA »

Alder BioPharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

RF

Regions Financial

$16.24

-0.01 (-0.06%)

16:59
02/22/19
02/22
16:59
02/22/19
16:59
Syndicate
Breaking Syndicate news story on Regions Financial »

Regions Financial files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

HL

Hecla Mining

$2.59

-0.145 (-5.31%)

16:58
02/22/19
02/22
16:58
02/22/19
16:58
Syndicate
Breaking Syndicate news story on Hecla Mining »

Hecla Mining files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$50.99

0.84 (1.68%)

, CELG

Celgene

$89.15

0.54 (0.61%)

16:52
02/22/19
02/22
16:52
02/22/19
16:52
Hot Stocks
Bristol-Myers files proxy statement in connection with proposed Celgene merger »

Bristol-Myers Squibb…

BMY

Bristol-Myers

$50.99

0.84 (1.68%)

CELG

Celgene

$89.15

0.54 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 28

    Feb

  • 18

    May

  • 20

    May

  • 28

    May

TEN

Tenneco

$36.29

0.76 (2.14%)

16:48
02/22/19
02/22
16:48
02/22/19
16:48
Earnings
Tenneco sees FY19 revenue growth up 4%-5%, consensus $4.65B »

The company expects 2019…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

TEN

Tenneco

$36.29

0.76 (2.14%)

16:46
02/22/19
02/22
16:46
02/22/19
16:46
Earnings
Tenneco reports preliminary Q4 revenue $4.3B, consensus $4.3B »

Sees FY18 EPS "near…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

XRX

Xerox

$31.50

0.16 (0.51%)

16:44
02/22/19
02/22
16:44
02/22/19
16:44
Conference/Events
Xerox management to meet with Loop Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

TWTR

Twitter

$31.70

0.94 (3.06%)

16:38
02/22/19
02/22
16:38
02/22/19
16:38
Hot Stocks
Twitter board member Evan Williams to step down at end of month »

On February 22, 2019,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

ALLY

Ally Financial

$26.95

-0.07 (-0.26%)

16:34
02/22/19
02/22
16:34
02/22/19
16:34
Hot Stocks
Ally Financial CEO sells over 97,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Mar

  • 28

    May

DAL

Delta Air Lines

$51.52

0.04 (0.08%)

16:33
02/22/19
02/22
16:33
02/22/19
16:33
Hot Stocks
Delta Air Lines' West sells 36,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REN

Resolute Energy

$31.61

0.09 (0.29%)

16:30
02/22/19
02/22
16:30
02/22/19
16:30
Hot Stocks
Resolute Energy stockholders approve merger with Cimarex Energy »

Resolute Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

16:30
02/22/19
02/22
16:30
02/22/19
16:30
Options
Preliminary option volume of 18.8M today »

Preliminary option volume…

ORI

Old Republic

$21.14

0.04 (0.19%)

16:22
02/22/19
02/22
16:22
02/22/19
16:22
Hot Stocks
Old Republic raises quarterly dividend to 20c from 19.5c per share »

This dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
02/22/19
02/22
16:20
02/22/19
16:20
Options
Closing CBOE SPX and VIX Index summary for February 22nd »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
02/22/19
02/22
16:17
02/22/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFC

Ellington Financial

$16.97

-0.01 (-0.06%)

16:16
02/22/19
02/22
16:16
02/22/19
16:16
Hot Stocks
Ellington Financial to convert to a Delaware corporation »

Ellington Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
02/22/19
02/22
16:16
02/22/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENLC

EnLink Midstream

$11.38

0.08 (0.71%)

16:14
02/22/19
02/22
16:14
02/22/19
16:14
Syndicate
Breaking Syndicate news story on EnLink Midstream »

EnLink Midstream files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 07

    Aug

  • 06

    Nov

KHC

Kraft Heinz

$34.97

-13.225 (-27.44%)

, K

Kellogg

$56.72

-1.61 (-2.76%)

16:13
02/22/19
02/22
16:13
02/22/19
16:13
On The Fly
Fly Intel: Wall Street's top stories for Friday »

Stocks opened in positive…

KHC

Kraft Heinz

$34.97

-13.225 (-27.44%)

K

Kellogg

$56.72

-1.61 (-2.76%)

STMP

Stamps.com

$83.32

-114.76 (-57.94%)

INTC

Intel

$52.43

1.03 (2.00%)

ZG

Zillow

$43.65

8.58 (24.47%)

Z

Zillow

$44.23

9.2 (26.26%)

W

Wayfair

$150.01

32.87 (28.06%)

ROKU

Roku

$64.85

13.38 (26.00%)

DPLO

Diplomat Pharmacy

$5.87

-7.59 (-56.39%)

CASA

Casa Systems

$10.29

-1.67 (-13.96%)

DBX

Dropbox

$23.49

-2.09 (-8.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 27

    Feb

  • 28

    Feb

  • 03

    Mar

  • 05

    Mar

  • 06

    Mar

  • 07

    Mar

  • 11

    Mar

  • 11

    Mar

  • 12

    Mar

  • 13

    Mar

  • 25

    Mar

  • 25

    Mar

  • 26

    Mar

SVA

Sinovac Biotech

$6.55

0.08 (1.24%)

16:11
02/22/19
02/22
16:11
02/22/19
16:11
Hot Stocks
Sinovac Biotech trading halted by the Nasdaq »

The Nasdaq Stock Market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.